Workflow for Mass Spectrometry-Based Untargeted Metabolomics

In systems biology research, metabolomics acts as a critical bridge linking the genome, transcriptome, and proteome, and has increasingly become a key tool for elucidating biological processes. Specifically, untargeted metabolomics is widely employed in studies of disease mechanisms, biomarker discovery, and drug development due to its broad metabolite coverage and high discovery potential. Mass spectrometry, with its high sensitivity and resolution, serves as the central platform for untargeted metabolomics analysis. This article provides a comprehensive overview of the complete workflow for mass spectrometry-based untargeted metabolomics, highlighting key technical steps and strategies for their optimization.

What is Untargeted Metabolomics?

Untargeted metabolomics involves the comprehensive detection and analysis of as many small molecule metabolites in a sample as possible without predefining target metabolites. This global profiling approach enables the discovery of unknown metabolites and potential biomarkers.

Compared with targeted metabolomics, its main features are:

• Broader metabolite coverage

• Independence from pre-defined metabolite lists

• Suitability for exploratory research

Advantages of Mass Spectrometry

Mass spectrometry offers several advantages in untargeted metabolomics:

1. High Sensitivity and Wide Dynamic Range

Mass spectrometry can detect low-abundance metabolites, making it well suited for the analysis of complex biological samples, including plasma, tissues, and cell lysates.

2. High Resolution and Accurate Mass Measurement

High-resolution mass spectrometers, such as Orbitrap and Time-of-Flight (TOF) instruments, can achieve sub-ppm mass accuracy, thereby facilitating reliable metabolite identification.

3. Compatibility with Multiple Separation Platforms

Mass spectrometry is frequently coupled with chromatographic separation techniques, including liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS), enabling the analysis of a wide range of metabolite classes.

Standard Workflow for Untargeted Metabolomics

1. Experimental Design

A well-designed experiment is the foundation of a successful metabolomics study. Key considerations include sample grouping (control versus experimental groups), the number of biological replicates (typically ≥5), randomization strategies, batch effect control, and the inclusion of quality control (QC) samples.

Key Consideration:

Minimize systematic bias and improve statistical robustness.

2. Sample Collection and Preparation

Sample handling directly affects data quality and represents one of the most critical steps in the workflow. Common sample types include serum/plasma, urine, tissue specimens, and cultured cells.

Typical preparation procedures include:

• Rapid metabolic quenching (e.g., liquid nitrogen freezing)

• Protein precipitation (commonly using methanol or acetonitrile)

• Centrifugation and collection of the supernatant

• Sample drying and reconstitution

Important Considerations:

• Avoid repeated freeze-thaw cycles

• Maintain consistency across sample processing procedures

• Control processing temperatures (typically at 4°C or below)

3. Chromatographic Separation

Because metabolites exhibit substantial chemical diversity, no single analytical method can comprehensively cover all metabolite classes. Therefore, optimization of chromatographic separation strategies is essential.

Common chromatographic approaches include:

• Reverse-Phase Liquid Chromatography (RPLC): Suitable for hydrophobic metabolites, such as lipids

• Hydrophilic Interaction Liquid Chromatography (HILIC): Suitable for polar metabolites, including amino acids and organic acids

• Gas Chromatography (GC): Suitable for volatile or derivatizable metabolites

The combination of multiple chromatographic methods can significantly enhance metabolome coverage.

4. Mass Spectrometry Data Acquisition

The data acquisition strategy directly influences the depth and quality of downstream analyses. Common acquisition modes include:

• Full Scan

• Data-Dependent Acquisition (DDA)

• Data-Independent Acquisition (DIA)

Key parameters requiring optimization include:

• Ionization source type (ESI/APCI)

• Positive and negative ionization modes

• Mass resolution settings

• Collision energy for MS/MS experiments

High-resolution mass spectrometry platforms provide rich fragmentation information, thereby improving the confidence and accuracy of metabolite identification.

5. Data Preprocessing

Raw mass spectrometry data must undergo standardized preprocessing before statistical analysis. Major preprocessing steps include:

• Peak detection

• Retention time correction

• Peak alignment

• Data normalization

Commonly used software platforms include:

• XCMS

• MZmine

• Compound Discoverer

6. Statistical Analysis

Differential metabolites are typically identified using multivariate statistical approaches. Common analytical methods include:

• Principal Component Analysis (PCA)

• Partial Least Squares Discriminant Analysis (PLS-DA)

• Volcano Plot Analysis

Typical screening criteria include:

• Variable Importance in Projection (VIP) > 1

• P-value < 0.05

• Fold Change (FC)

7. Metabolite Identification

Metabolite identification is generally considered the most challenging step in untargeted metabolomics.

Identification is commonly based on multiple lines of evidence, including:

• Accurate mass measurements (m/z)

• Fragment ion spectra (MS/MS)

• Retention time information

• Database matching

To improve identification confidence, a multi-evidence integration strategy is typically employed.

8. Pathway Analysis

Differential metabolites are mapped onto metabolic pathways to facilitate biological interpretation. Commonly used tools include MetaboAnalyst and KEGG Pathway databases.

Pathway analysis can reveal:

• Alterations in metabolic networks

• Key regulatory pathways

• Disease-associated molecular mechanisms

The workflow of mass spectrometry-based untargeted metabolomics encompasses multiple critical stages, ranging from experimental design and sample preparation to data processing and biological interpretation. Each step has a direct impact on the reliability, reproducibility, and biological relevance of the final results. With ongoing advances in high-resolution mass spectrometry technologies and bioinformatics algorithms, untargeted metabolomics is rapidly evolving toward higher throughput, greater analytical accuracy, and deeper biological insights. Consequently, establishing a robust and reproducible analytical workflow has become essential for generating high-quality metabolomics data. Leveraging advanced high-resolution mass spectrometry platforms and well-established data analysis pipelines, MtoZ Biolabs provides comprehensive one-stop untargeted metabolomics solutions, covering the entire process from sample preparation to biological interpretation, thereby supporting researchers in producing high-quality scientific outcomes.

MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

Related Services

Untargeted Metabolomics Service